Martingale Asset Management »

First Tracks Biotherapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $548k 27k 20.12

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
Abbvie (ABBV)
Exxon Mobil Corp
Cisco Systems (CSCO)
Visa (V)
Merck & Co (MRK)

View all positions for Martingale Asset Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics